Monkeypox, now named mpox, has emerged as a significant public threat, as evidenced by
the 2022 outbreak affecting over seventy countries globally. This infectious disease presents …

Monkeypox virus (MPXV), a member of the Orthopoxvirus genus, shares its genus with
Variola virus (VARV), the causative agent of smallpox, and Vaccinia virus (VACV), used for …

Monkeypox, a zoonotic disease caused by the Monkeypox virus, has emerged as a potential
threat with pandemic potential in various regions. While it is challenging to predict specific …

Mpox is a zoonotic disease caused by the monkeypox virus (MPV), primarily found in
Central and West African countries. The typical presentation of the disease before the 2022 …

Background: Available assays to measure pox virus neutralizing antibody titers are
laborious and take up to 5 days. In addition, assays to measure T cell responses require the …

This study provides an in-depth analysis of mpox, encompassing its history, characteristics,
epidemiology, diagnostics, treatment options, and the ongoing evolution of the virus and its …

Globally, the COVID-19 pandemic had a significant impact on the health, social, and
economic systems, triggering lasting damage and exposing the complexity of the problem …

Introduction An increased incidence of human Monkeypox (Mpox) cases was recently
observed worldwide, including in Cameroon. To ensure efficient preparedness and …

Mpox virus (MPXV) has consistently caused human infections since the first reported case in
1970, with the initial outbreaks primarily attributed to sporadic zoonotic transmissions. In …

Background: An emerging monkeypox outbreak in many countries caused the WHO to
declare the disease an international public health problem. This study aimed to explore …